Skip to content

Study for the relationship between propofol spontaneous body movement and injection pain

Study for the relationship between propofol spontaneous body movement and injection pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021923
Enrollment
Unknown
Registered
2019-03-16
Start date
2019-04-01
Completion date
Unknown
Last updated
2019-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

propofol induced body movements during general anesthesia induction in children patients and its potential pre-treatment methods

Interventions

Mixed group and Propofol group:Propofol in combination with lidocaine (propofol plus 1ml lidocaine for every 20ml)
Midazolam group and propofol group:Intravenous injection of midazolam 0.1mg/kg was performed 2 minutes before induction
Sufentanil group and propofol group:Sufentanil was intravenously injected at 0.3ug/kg.min in advance
Dexmedetomidine group and propofol group:4ug/kg.h pre-pump dexmedetomidine for 10 minutes
Ketamine group 1 and propofol group:0.5mg/kg ketamine was intravenously injected in advance
Ketamine group 2 and propofol group:0.6mg/kg ketamine was intravenously injected in advance
Ketamine group 3 and propofol group:0.7mg/kg ketamine was intravenously injected in advance
Ketamine group 4 and propofol group:0.8mg/kg ketamine was intravenously injected in advance

Sponsors

The Second Affiliated Hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. children undergoing elective surgery under general anesthesia; ASA I-II grade; Aged 4-12 years; cooperation with the establishment of placement of intravenous cannulation; capable of a commucation with experimenters; 2. adults undergoing elective surgeryunder general anesthesia; ASA I-II grade; Aged 18-50 years old; surgery is expected no more than 3 h.

Exclusion criteria

Exclusion criteria: 1. Obesity (BMI>30); 2. with mental illness or cerebral disease;movement disorders; 3. heart, lung, liver serious abnormal renal function; 4. with allergy history to drug used or their composition; a history of convulsive seizures or asthma; 5. participating in other clinical trials of patient; 6. Other reasons are not suitable for clinical subjects according to the researchers.

Design outcomes

Primary

MeasureTime frame
The presence of pain in anesthesia induction;whether there is a body reaction;

Secondary

MeasureTime frame
BIS values during anesthesia induction (every 5s);BIS values and time at the beginning of body movement;BIS value and time at the end of body movement;BIS value at the initial of induction;The severaty of body movement;

Countries

China

Contacts

Public ContactSiyuan Li

The Second Affiliated Hospital of Xi'an Jiaotong University

foxlsy@163.com+86 18681875961

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026